CIK 0001649094
- Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464233385
- Phone
- +1 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 88 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-30 | Fairman Jeff VP, Research | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2022-10-26 | Fairman Jeff VP, Research | Sale | −10,000 | $40.00 | $400K | 286,227 |
| 2022-10-11 | Fairman Jeff VP, Research | Sale | −5,000 | $25.50 | $128K | 296,227 |
| 2022-09-06 | Fairman Jeff VP, Research | Sale | −4,664 | $26.54 | $124K | 301,563 |
| 2022-09-06 | Fairman Jeff VP, Research | Sale | −336 | $27.14 | $9K | 301,227 |
| 2022-09-02 | Fairman Jeff VP, Research | Shares withheld for taxes | −519 | $26.38 | $14K | 17,143 |
| 2022-08-05 | Fairman Jeff VP, Research | Sale | −5,000 | $25.70 | $129K | 306,227 |
| 2022-08-04 | Fairman Jeff VP, Research | Sale | −10,000 | $25.50 | $255K | 311,227 |
| 2022-05-20 | Fairman Jeff VP, Research | Sale | −4,112 | $25.50 | $105K | 321,227 |
| 2022-05-05 | Fairman Jeff VP, Research | Sale | −888 | $25.80 | $23K | 325,339 |
| 2022-04-05 | Fairman Jeff VP, Research | Sale | −5,000 | $25.59 | $128K | 326,227 |
| 2022-03-11 | Fairman Jeff VP, Research | Sale | −10,000 | $25.50 | $255K | 331,227 |
| 2022-03-02 | Fairman Jeff VP, Research | Grant or award | +6,000 | 16,629 | ||
| 2022-03-02 | Fairman Jeff VP, Research | Grant or award · Stock Option (right to buy) | +33,000 | 33,000 |
Page 1 of 1 · 14 trades